Transgene: Corporate Overview (Transgene) - Apr 1, 2015 - Anticipated data from P2b part of TIME trial (NCT01383148) for NSCLC at ASCO (May 29 – June 2, 2015); Anticipated initiation of P3 part of TIME trial (NCT01383148) for NSCLC by Q1 2016
Anticipated P2b data • Anticipated trial initiation date • Non Small Cell Lung Cancer
|